Moeni, M.; Edokali, M.; Bacchetti, A.; Davy, J.; Sun, H.; Rogers, M.; Cespedes, O.; Aslam, Z.; Britton, A.; Khazin, L.;
et al. Theranostic Iron Oxide Nanoparticles for Controlled Oxaliplatin Release Under Simulated Circulation and Cytotoxicity Evaluation in Colorectal Cancer Cell Lines. Processes 2026, 14, 597.
https://doi.org/10.3390/pr14040597
AMA Style
Moeni M, Edokali M, Bacchetti A, Davy J, Sun H, Rogers M, Cespedes O, Aslam Z, Britton A, Khazin L,
et al. Theranostic Iron Oxide Nanoparticles for Controlled Oxaliplatin Release Under Simulated Circulation and Cytotoxicity Evaluation in Colorectal Cancer Cell Lines. Processes. 2026; 14(4):597.
https://doi.org/10.3390/pr14040597
Chicago/Turabian Style
Moeni, Masome, Mohamed Edokali, Alistair Bacchetti, Joshua Davy, Hanyang Sun, Matthew Rogers, Oscar Cespedes, Zabeada Aslam, Andrew Britton, Leah Khazin,
and et al. 2026. "Theranostic Iron Oxide Nanoparticles for Controlled Oxaliplatin Release Under Simulated Circulation and Cytotoxicity Evaluation in Colorectal Cancer Cell Lines" Processes 14, no. 4: 597.
https://doi.org/10.3390/pr14040597
APA Style
Moeni, M., Edokali, M., Bacchetti, A., Davy, J., Sun, H., Rogers, M., Cespedes, O., Aslam, Z., Britton, A., Khazin, L., Schneider, J. E., Valdastri, P., Menzel, R., Volpato, M., & Hassanpour, A.
(2026). Theranostic Iron Oxide Nanoparticles for Controlled Oxaliplatin Release Under Simulated Circulation and Cytotoxicity Evaluation in Colorectal Cancer Cell Lines. Processes, 14(4), 597.
https://doi.org/10.3390/pr14040597
